The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Regeneron Pharmaceuticals (NASDAQ:REGN), Boston Scientific Corp (NYSE:BSX), Humana (NYSE:HUM), McKesson Corp (NYSE:MCK).
The investment seeks long-term growth of capital.
The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities. It invests primarily in equity securities, including common and preferred stock, and depositary receipts. The fund may invest in the securities of issuers of all capitalization sizes and may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.
The average market capitalization across the Invesco Health Care C MF is 153.75B. The market cap for tickers in the group ranges from 61.83B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is MCK at 61.83B.
The average weekly volume growth across all stocks in the Invesco Health Care C MF was -55%. For the same stocks of the MF, the average monthly volume growth was -60% and the average quarterly volume growth was -61%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 49
P/E Growth Rating: 45
Price Growth Rating: 44
SMR Rating: 58
Profit Risk Rating: 25
Seasonality Score: 2 (-100 ... +100)